Publisher: Adis International
ISSN: 0114-9954
Source: Reactions Weekly, Vol.1, Iss.1305, 2010-01, pp. : 1-1
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Serious infections reported with etanercept and infliximab
Reactions Weekly, Vol. 1, Iss. 1024, 2004-01 ,pp. :
Etanercept: increased risk of TB reactivation?
Reactions Weekly, Vol. 1, Iss. 1021, 2004-01 ,pp. :
Novel Drugs for the Prevention and Treatment of Acute GVHD
Current Pharmaceutical Design, Vol. 14, Iss. 20, 2008-07 ,pp. :
Increased risk of infections with alemtuzumab?
Reactions Weekly, Vol. 1, Iss. 1109, 2006-01 ,pp. :
Infliximab shows potential in the treatment of corticosteroid-refractory acute GVHD
Inpharma, Vol. 1, Iss. 1303, 2001-01 ,pp. :